News

Judge Restricts Copycats of Novo Nordisk’s Weight Loss Drug
A federal judge refused to allow drug compounders to keep making copycats of Novo Nordisk A/S’s weight loss drug while a ...
FDA stops sale of copycat versions of Ozempic and Wegovy: What to do if you’re taking them
Many compounding pharmacies are no longer allowed to make cheaper versions of semaglutide and other GLP-1 drugs. A doctor ...
Fierce Pharma1d
US court decision stops compounders from making knockoffs of Novo Nordisk's semaglutide
The ruling means that small-scale compounders must immediately stop making their versions of Novo’s Ozempic and Wegovy, while ...
NBC Los Angeles2d
Novo Nordisk scores major legal win that bars many compounded versions of Wegovy, Ozempic
Patients flocked to those Ozempic, Wegovy copycats when the branded drugs were in short supply, or if they didn’t have ...
Novo Nordisk wins case to kick knockoff Ozempic off the market, but it may not last
Novo Nordisk scored a legal win against compounders of its blockbuster GLP-1 drugs. But it may not end the copycats.
Novo Nordisk Wins Legal Battle To Curb Unsafe Knockoff Versions Of Ozempic, Wegovy
The court ruled in favor of Novo Nordisk and the FDA, rejecting a compounding pharmacy group's attempt to stop the FDA's ...
The Motley Fool4d
Novo Nordisk Investors Just Got Terrible News. Should You Sell the Stock?
Novo Nordisk's shares fell on news of a clinical success from its biggest rival. As a result, it could lose market share in an important area. However, there are still strong reasons to invest in ...
The Motley Fool4d
Why Novo Nordisk Stock Popped Today
Novo Nordisk has submitted an "Ozempic pill" to the FDA for approval. The new pill will probably be popular (if approved). However, making it will require Novo Nordisk to ramp up semaglutide ...
Lilly soars after weight-loss pill results rival Ozempic’s
Eli Lilly and Co. shares surged after data showed its experimental weight-loss pill worked as well as the Ozempic shot.